Nyheter

First pharma company joins IMPRESS-Norway

Roche is the first pharmaceutical company included in the national clinical study in cancer precision medicine called IMPRESS-Norway.

Jan 29, 20213 min read

CONNECT is a new initiative aiming to ensure that precision medicine reaches the patients.

Dec 21, 20203 min read

IMPRESS-Norway, a large national study on precision medicine against cancer, starts in the beginning of 2021.

Oct 12, 20203 min read